Welcome to NGN-Capital Profile Portfolio Contact Us NGN BioMed Opportunity I NGN BioMed Opportunity II General Partners Partners C.F.O. Venture Partners Senior Advisors Advisory Board Email Us US Offices European Office Profile Our Team The Location Contact Us Civil Law Law of Succession Family Law Intellectual Property Commercial Law Corporate Law Real Estate Foreclosure Insolvency Forced Sale Labour Law Criminal Law International Law Community Law Relocation Network Solutions E-Business Internet Web Design Profile Portfolio Companies -NGN BioMed Opportunity I -NGN BioMed Opportunity II Contact Us NGN Capital is a venture capital firm dedicated to healthcare investing, focusing on ventures with the potential to achieve above average private equity returns with an emphasis on later stage investments. The funds have flexibility to invest in a broad cross section of healthcare and biotechnology segments including drug products, medical devices and other healthcare segments like services. The funds are diversified by stage, from later stage to selected early stage opportunities, as well as by geography by investing predominantly in the US and in Europe. NGN Capital is comprised of a professional team and advisors with exceptional investment and management backgrounds in the healthcare and venture capital industry from leading institutions on a global basis. NGNs professionals were directly involved in transformational developments in healthcare that led to significant realizations for investors. NGNs advisors are recognized experts in their respective fields of healthcare, science and corporate value creation and work actively with NGNs professionals. Collectively, NGNs professionals and advisors bring substantial value creation achievements and commercial expertise in healthcare ventures to the investments of NGN BioMed Opportunity I and NGN BioMed Opportunity II and their prospective portfolio companies. NGN Capital's North American offices are in New York, NY, Greenwich, CT and its European office is in Heidelberg, Germany. Top of Page Print Version About NGN | Investment Professionals | Advisors | News | Contact Us Copyright © 2015 NGN Capital Rights Reserved